KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Inventory: 2020-2024

Historic Change in Inventory for Moderna (MRNA) over the last 5 years, with Dec 2024 value amounting to -$83.0 million.

  • Moderna's Change in Inventory rose 727.27% to $91.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$78.0 million, marking a year-over-year decrease of 1.30%. This contributed to the annual value of -$83.0 million for FY2024, which is 88.89% up from last year.
  • Moderna's Change in Inventory amounted to -$83.0 million in FY2024, which was up 88.89% from -$747.0 million recorded in FY2023.
  • Over the past 5 years, Moderna's Change in Inventory peaked at $1.4 billion during FY2021, and registered a low of -$747.0 million during FY2023.
  • For the 3-year period, Moderna's Change in Inventory averaged around -$440.7 million, with its median value being -$492.0 million (2022).
  • In the last 5 years, Moderna's Change in Inventory spiked by 2,865.96% in 2021 and then tumbled by 135.29% in 2022.
  • Yearly analysis of 5 years shows Moderna's Change in Inventory stood at $47.0 million in 2020, then skyrocketed by 2,865.96% to $1.4 billion in 2021, then tumbled by 135.29% to -$492.0 million in 2022, then tumbled by 51.83% to -$747.0 million in 2023, then spiked by 88.89% to -$83.0 million in 2024.